Skip to main content
Top
Published in: Cardiovascular Intervention and Therapeutics 4/2018

01-10-2018 | Images in Cardiovascular Intervention

Very late scaffold thrombosis one week after the discontinuation of dual antiplatelet therapy

Authors: Futoshi Yamanaka, Koki Shishido, Shigeru Saito

Published in: Cardiovascular Intervention and Therapeutics | Issue 4/2018

Login to get access

Excerpt

A 59-year-old man was admitted to the hospital due to effort angina pectoris; the coronary angiogram demonstrated critical stenosis in the distal right coronary artery (Fig. 1a). A bioresorbable vascular scaffold (BVS) 3.5–18 (Abbott’s Cor) was implanted (Fig. 1b, c), after which the symptoms improved. On the 1-year follow up, angiography demonstrated no restenosis at the BVS site, and 22 months later after the BVS implantation, clopidogrel treatment was discontinued (keeping an aspirin 100 mg/day). However, 1 week after the discontinuation of dual antiplatelet therapy, very late bioresorbable vascular scaffold thrombosis occurred (Fig. 1d). The clinical symptoms demonstrated sudden onset chest pain and ST elevation in II, III, and aVf. Emergency coronary angiography showed definite thrombosis according to the Valve Academic Research Consortium criteria. Following aspiration thrombectomy, antegrade flow recovered. Optical coherence tomography imaging demonstrated scaffold discontinuity with considerable thrombus (Fig. 1e, f, online Video).
Appendix
Available only for authorised users
Literature
1.
go back to reference Onuma Y, Serruys PW, Muramatsu T, et al. Incidence and imaging outcomes of acute scaffold disruption and late structural discontinuity after implantation of the absorb Everolimus-Eluting fully bioresorbable vascular scaffold: optical coherence tomography assessment in the ABSORB cohort B Trial (A Clinical Evaluation of the Bioabsorbable Everolimus Eluting Coronary Stent System in the Treatment of Patients With De Novo Native Coronary Artery Lesions). JACC Cardiovasc Interv. 2014;7:1400–11.CrossRef Onuma Y, Serruys PW, Muramatsu T, et al. Incidence and imaging outcomes of acute scaffold disruption and late structural discontinuity after implantation of the absorb Everolimus-Eluting fully bioresorbable vascular scaffold: optical coherence tomography assessment in the ABSORB cohort B Trial (A Clinical Evaluation of the Bioabsorbable Everolimus Eluting Coronary Stent System in the Treatment of Patients With De Novo Native Coronary Artery Lesions). JACC Cardiovasc Interv. 2014;7:1400–11.CrossRef
2.
go back to reference Kimura T, Kozuma K, Tanabe K, et al. A randomized trial evaluating everolimus-eluting absorb bioresorbable scaffolds vs. everolimus-eluting metallic stents in patients with coronary artery disease: ABSORB Japan. Eur Heart J. 2015;36:3332–42.CrossRef Kimura T, Kozuma K, Tanabe K, et al. A randomized trial evaluating everolimus-eluting absorb bioresorbable scaffolds vs. everolimus-eluting metallic stents in patients with coronary artery disease: ABSORB Japan. Eur Heart J. 2015;36:3332–42.CrossRef
Metadata
Title
Very late scaffold thrombosis one week after the discontinuation of dual antiplatelet therapy
Authors
Futoshi Yamanaka
Koki Shishido
Shigeru Saito
Publication date
01-10-2018
Publisher
Springer Japan
Published in
Cardiovascular Intervention and Therapeutics / Issue 4/2018
Print ISSN: 1868-4300
Electronic ISSN: 1868-4297
DOI
https://doi.org/10.1007/s12928-017-0485-6

Other articles of this Issue 4/2018

Cardiovascular Intervention and Therapeutics 4/2018 Go to the issue